 | • レポートコード：QYR2104Z5272 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、皮膚がん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、凍結手術、免疫療法、光線力学療法、手術、その他治療）、用途別市場規模（病院、診療所、がん研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・皮膚がん治療薬の市場動向 ・企業の競争状況、市場シェア ・皮膚がん治療薬の種類別市場規模（化学療法、放射線療法、凍結手術、免疫療法、光線力学療法、手術、その他治療） ・皮膚がん治療薬の用途別市場規模（病院、診療所、がん研究センター、その他） ・皮膚がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・皮膚がん治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Merck、Novartis、GlaxoSmithKline、Bristol Myers Squibb、Eli Lilly、Roche、Qiagen、Boehringer Ingelheim、Aqua Pharmaceuticals、Meda、Elekta AB、Varian Medical Systems、Bausch Health） ・結論 |
On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the extension of current therapies are fueling the growth of the market. However, high cost associated with therapy, a stringent regulatory environment, and the lack of awareness in the general population could adversely affect market growth.
In 2017, North America was the largest regional market, in terms of revenue.
Market Analysis and Insights: Global Skin Cancer Therapeutics Market
The global Skin Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Skin Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Skin Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Skin Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Skin Cancer Therapeutics market.
Global Skin Cancer Therapeutics Scope and Market Size
Skin Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Skin Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Radiotherapy
Cryosurgery
Immune Therapy
Photodynamic Therapy
Surgery
Other Treatments
Segment by Application
Hospital
Clinic
Cancer Research Center
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Merck
Novartis
GlaxoSmithKline
Bristol Myers Squibb
Eli Lilly
Roche
Qiagen
Boehringer Ingelheim
GlaxoSmithKline
Bristol Myers Squibb
Elekta AB
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.2.4 Cryosurgery
1.2.5 Immune Therapy
1.2.6 Photodynamic Therapy
1.2.7 Surgery
1.2.8 Other Treatments
1.3 Market by Application
1.3.1 Global Skin Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Cancer Research Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Skin Cancer Therapeutics Market Perspective (2016-2027)
2.2 Skin Cancer Therapeutics Growth Trends by Regions
2.2.1 Skin Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Skin Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Skin Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Skin Cancer Therapeutics Industry Dynamic
2.3.1 Skin Cancer Therapeutics Market Trends
2.3.2 Skin Cancer Therapeutics Market Drivers
2.3.3 Skin Cancer Therapeutics Market Challenges
2.3.4 Skin Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Skin Cancer Therapeutics Players by Revenue
3.1.1 Global Top Skin Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Skin Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Skin Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Skin Cancer Therapeutics Revenue
3.4 Global Skin Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Skin Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Cancer Therapeutics Revenue in 2020
3.5 Skin Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Skin Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Skin Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Skin Cancer Therapeutics Breakdown Data by Type
4.1 Global Skin Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Skin Cancer Therapeutics Forecasted Market Size by Type (2022-2027)
5 Skin Cancer Therapeutics Breakdown Data by Application
5.1 Global Skin Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Skin Cancer Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Skin Cancer Therapeutics Market Size (2016-2027)
6.2 North America Skin Cancer Therapeutics Market Size by Type
6.2.1 North America Skin Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Skin Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Skin Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Skin Cancer Therapeutics Market Size by Application
6.3.1 North America Skin Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Skin Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Skin Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Skin Cancer Therapeutics Market Size by Country
6.4.1 North America Skin Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Skin Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Skin Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Skin Cancer Therapeutics Market Size by Type
7.2.1 Europe Skin Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Skin Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Skin Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Skin Cancer Therapeutics Market Size by Application
7.3.1 Europe Skin Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Skin Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Skin Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Skin Cancer Therapeutics Market Size by Country
7.4.1 Europe Skin Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Skin Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Skin Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Skin Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Skin Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Skin Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Skin Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Skin Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Skin Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Skin Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Skin Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Skin Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Skin Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Skin Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Skin Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Skin Cancer Therapeutics Market Size by Type
9.2.1 Latin America Skin Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Skin Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Skin Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Skin Cancer Therapeutics Market Size by Application
9.3.1 Latin America Skin Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Skin Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Skin Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Skin Cancer Therapeutics Market Size by Country
9.4.1 Latin America Skin Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Skin Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Skin Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Skin Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Skin Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Skin Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Skin Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Skin Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Skin Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Skin Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Skin Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Skin Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Skin Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Skin Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Skin Cancer Therapeutics Introduction
11.1.4 Pfizer Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Skin Cancer Therapeutics Introduction
11.2.4 Merck Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Skin Cancer Therapeutics Introduction
11.3.4 Novartis Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Skin Cancer Therapeutics Introduction
11.4.4 GlaxoSmithKline Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Bristol Myers Squibb
11.5.1 Bristol Myers Squibb Company Details
11.5.2 Bristol Myers Squibb Business Overview
11.5.3 Bristol Myers Squibb Skin Cancer Therapeutics Introduction
11.5.4 Bristol Myers Squibb Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.5.5 Bristol Myers Squibb Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Skin Cancer Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Skin Cancer Therapeutics Introduction
11.7.4 Roche Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.7.5 Roche Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Details
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Skin Cancer Therapeutics Introduction
11.8.4 Qiagen Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.8.5 Qiagen Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Skin Cancer Therapeutics Introduction
11.9.4 Boehringer Ingelheim Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Aqua Pharmaceuticals
11.10.1 Aqua Pharmaceuticals Company Details
11.10.2 Aqua Pharmaceuticals Business Overview
11.10.3 Aqua Pharmaceuticals Skin Cancer Therapeutics Introduction
11.10.4 Aqua Pharmaceuticals Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.10.5 Aqua Pharmaceuticals Recent Development
11.11 Meda
11.11.1 Meda Company Details
11.11.2 Meda Business Overview
11.11.3 Meda Skin Cancer Therapeutics Introduction
11.11.4 Meda Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.11.5 Meda Recent Development
11.12 Elekta AB
11.12.1 Elekta AB Company Details
11.12.2 Elekta AB Business Overview
11.12.3 Elekta AB Skin Cancer Therapeutics Introduction
11.12.4 Elekta AB Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.12.5 Elekta AB Recent Development
11.13 Varian Medical Systems
11.13.1 Varian Medical Systems Company Details
11.13.2 Varian Medical Systems Business Overview
11.13.3 Varian Medical Systems Skin Cancer Therapeutics Introduction
11.13.4 Varian Medical Systems Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.13.5 Varian Medical Systems Recent Development
11.14 Bausch Health
11.14.1 Bausch Health Company Details
11.14.2 Bausch Health Business Overview
11.14.3 Bausch Health Skin Cancer Therapeutics Introduction
11.14.4 Bausch Health Revenue in Skin Cancer Therapeutics Business (2016-2021)
11.14.5 Bausch Health Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Skin Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Cryosurgery
Table 5. Key Players of Immune Therapy
Table 6. Key Players of Photodynamic Therapy
Table 7. Key Players of Surgery
Table 8. Key Players of Other Treatments
Table 9. Global Skin Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Skin Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Skin Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Skin Cancer Therapeutics Market Share by Regions (2016-2021)
Table 13. Global Skin Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Skin Cancer Therapeutics Market Share by Regions (2022-2027)
Table 15. Skin Cancer Therapeutics Market Trends
Table 16. Skin Cancer Therapeutics Market Drivers
Table 17. Skin Cancer Therapeutics Market Challenges
Table 18. Skin Cancer Therapeutics Market Restraints
Table 19. Global Skin Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Skin Cancer Therapeutics Market Share by Players (2016-2021)
Table 21. Global Top Skin Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer Therapeutics as of 2020)
Table 22. Ranking of Global Top Skin Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Skin Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Skin Cancer Therapeutics Product Solution and Service
Table 26. Date of Enter into Skin Cancer Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Skin Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Skin Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 30. Global Skin Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Skin Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Skin Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Skin Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 34. Global Skin Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Skin Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Skin Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Skin Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Skin Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Skin Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Skin Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Skin Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Skin Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Skin Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Skin Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Skin Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Skin Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Skin Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Skin Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Skin Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Skin Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Skin Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Skin Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Skin Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Skin Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Skin Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Skin Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Skin Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Skin Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Skin Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Skin Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Skin Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Skin Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Skin Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Skin Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Skin Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Skin Cancer Therapeutics Product
Table 69. Pfizer Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Skin Cancer Therapeutics Product
Table 74. Merck Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Skin Cancer Therapeutics Product
Table 79. Novartis Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Skin Cancer Therapeutics Product
Table 84. GlaxoSmithKline Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Bristol Myers Squibb Company Details
Table 87. Bristol Myers Squibb Business Overview
Table 88. Bristol Myers Squibb Skin Cancer Therapeutics Product
Table 89. Bristol Myers Squibb Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Bristol Myers Squibb Recent Development
Table 91. Eli Lilly Company Details
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Skin Cancer Therapeutics Product
Table 94. Eli Lilly Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Eli Lilly Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Skin Cancer Therapeutics Product
Table 99. Roche Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Roche Recent Development
Table 101. Qiagen Company Details
Table 102. Qiagen Business Overview
Table 103. Qiagen Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Qiagen Recent Development
Table 105. Boehringer Ingelheim Company Details
Table 106. Boehringer Ingelheim Business Overview
Table 107. Boehringer Ingelheim Skin Cancer Therapeutics Product
Table 108. Boehringer Ingelheim Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Boehringer Ingelheim Recent Development
Table 110. Aqua Pharmaceuticals Company Details
Table 111. Aqua Pharmaceuticals Business Overview
Table 112. Aqua Pharmaceuticals Skin Cancer Therapeutics Product
Table 113. Aqua Pharmaceuticals Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Aqua Pharmaceuticals Recent Development
Table 115. Meda Company Details
Table 116. Meda Business Overview
Table 117. Meda Skin Cancer Therapeutics Product
Table 118. Meda Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Meda Recent Development
Table 120. Elekta AB Company Details
Table 121. Elekta AB Business Overview
Table 122. Elekta AB Skin Cancer Therapeutics Product
Table 123. Elekta AB Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Elekta AB Recent Development
Table 125. Varian Medical Systems Company Details
Table 126. Varian Medical Systems Business Overview
Table 127. Varian Medical Systems Skin Cancer Therapeutics Product
Table 128. Varian Medical Systems Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 129. Varian Medical Systems Recent Development
Table 130. Bausch Health Company Details
Table 131. Bausch Health Business Overview
Table 132. Bausch Health Skin Cancer Therapeutics Product
Table 133. Bausch Health Revenue in Skin Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 134. Bausch Health Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Skin Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Cryosurgery Features
Figure 5. Immune Therapy Features
Figure 6. Photodynamic Therapy Features
Figure 7. Surgery Features
Figure 8. Other Treatments Features
Figure 9. Global Skin Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Cancer Research Center Case Studies
Figure 13. Others Case Studies
Figure 14. Skin Cancer Therapeutics Report Years Considered
Figure 15. Global Skin Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Skin Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Skin Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 18. Global Skin Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 19. Global Skin Cancer Therapeutics Market Share by Players in 2020
Figure 20. Global Top Skin Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer Therapeutics as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Skin Cancer Therapeutics Revenue in 2020
Figure 22. Global Skin Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 23. Global Skin Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 24. North America Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Skin Cancer Therapeutics Market Share by Type (2016-2027)
Figure 26. North America Skin Cancer Therapeutics Market Share by Application (2016-2027)
Figure 27. North America Skin Cancer Therapeutics Market Share by Country (2016-2027)
Figure 28. United States Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Skin Cancer Therapeutics Market Share by Type (2016-2027)
Figure 32. Europe Skin Cancer Therapeutics Market Share by Application (2016-2027)
Figure 33. Europe Skin Cancer Therapeutics Market Share by Country (2016-2027)
Figure 34. Germany Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Skin Cancer Therapeutics Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Skin Cancer Therapeutics Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Skin Cancer Therapeutics Market Share by Region (2016-2027)
Figure 44. China Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Skin Cancer Therapeutics Market Share by Type (2016-2027)
Figure 52. Latin America Skin Cancer Therapeutics Market Share by Application (2016-2027)
Figure 53. Latin America Skin Cancer Therapeutics Market Share by Country (2016-2027)
Figure 54. Mexico Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Skin Cancer Therapeutics Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Skin Cancer Therapeutics Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Skin Cancer Therapeutics Market Share by Country (2016-2027)
Figure 60. Turkey Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Skin Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Pfizer Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 66. GlaxoSmithKline Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 67. Bristol Myers Squibb Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 68. Eli Lilly Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 70. Qiagen Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 71. Boehringer Ingelheim Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 72. Aqua Pharmaceuticals Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 73. Meda Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 74. Elekta AB Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 75. Varian Medical Systems Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 76. Bausch Health Revenue Growth Rate in Skin Cancer Therapeutics Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の皮膚がん診断＆治療市場規模・現状・予測（2021年-2027年） On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the exte…- 世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 世界の皮膚がん診断＆治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Skin Cancer Diagnosis and Therapeutics Market The global Skin Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
- 世界の非黒色腫皮膚がん市場規模・現状・予測（2021年-2027年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…